CD8A and systemic lupus erythematosus: The identification of specific CD8+ T‐cell subsets, such as the CD8+ CD27+ CXCR3− population, which is dysregulated in SLE, has provided new insights into the mechanisms driving disease progression and highlights the potential for these cells to serve as biomarkers for disease severity [155].